期刊文献+

TLR9在CpG寡脱氧核苷酸所致种属特异性免疫效应中的意义 被引量:3

Toll-like receptor 9 in CpG oligodeoxynucleotides-induced species-specific immune responses
下载PDF
导出
摘要 目的:探讨TLR9在CpG寡脱氧核苷酸(CpG-ODN)种属特异性免疫效应中的意义。方法:CpG-ODN体外刺激人、猕猴、小鼠外周血单个核细胞(PBMC),ELISA测培养液IFN-α含量;RT-PCR检测PBMC中TLR9的表达水平。结果:CpG-ODN2216有效诱导人PBMC分泌IFN-α,而对猕猴和小鼠却无明显的免疫刺激活性;TLR9在人PBMC中均有表达,并且在CpG-ODN介导激活的人PBMC中表达上调;TLR9在猕猴PBMC中不表达。结论:TLR9是构成CpG-ODN种属特异性的重要分子基础。 Objective To determine the role of Toll-like receptor 9 (TLR9) in synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG dinucleotides (CpG-ODN) -induced species-specific immune responses. Methods CpG-ODN was co-cultured with peripheral blood mononuclear cells (PBMC) of humans, macaques and mice. The IFN-α in the supernatant was measured by ELISA. The reverse transcription PCR was used to analyze the expression levels of TLR9 mRNA in PBMC. Results CpG-ODN induced high amounts of IFN-α in human PBMC, but had no effect on maeaques and mice. The expression of TLR9 mRNA was observed in all human PBMC, and the levels of TLR9 mRNA were significantly up-regulated with the stimulation of CpG-ODN. We did not observe any expression of TLR9 mRNA in PBMC in macaques. Conclusion TLR9 underlies the moleeular foundation of CpG-ODN-induced species specificity.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2005年第5期533-535,共3页 Journal of Central South University :Medical Science
基金 湖南省科技攻关计划项目(04SK3040-3)
关键词 CPG寡脱氧核苷酸 Α干扰素 TOLL样受体9 种属特异性 CpG-oligodeoxynucleotides IFN-α Toll-like receptor 9 species specifieity
  • 相关文献

参考文献10

  • 1Krieg AM. CpG motifs in bacterial DNA and their immune effects[J]. Annu Rev Immunol,2002,20:709-760.
  • 2Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides[J]. Nature Immuol,2004,4(1):1-10.
  • 3李宁,范学工,陈朝晖,朱才.CpG-ODN体外抑制乙型肝炎病毒复制的研究[J].细胞与分子免疫学杂志,2005,21(1):103-105. 被引量:5
  • 4Leifer CA, Kennedy MN, Mazzoni A, et al.TLR9 is localized in the endoplasmic reticulum prior to stimulation[J]. J Immunol,2004,173(2):1179-1183.
  • 5Chuang TH, Lee J, Kline L, et al.Toll-like receptor 9 mediates CpG-DNA signaling[J]. J Leukoc Biol, 2002,71(3):538-544.
  • 6Bauer S,Kirschning CJ, Hacker H, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition[J]. Proc Natl Acad Sci USA,2001,98(16):9237-9242.
  • 7Verthelyi C, Klinman DM. Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates[J]. Clin Immunol, 2003,109(1):64-71.
  • 8Chuang TH, Lee J, Kline L, et al. Toll- like receptor 9 mediates CpG-DNA signaling[J]. J Leukoc Biol, 2002, 71(3): 538-544.
  • 9Mena A, Nichani AK, Popowych Y, et al. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by class A and class B CpG-oligonucleotides[J]. Oligonucleotides, 2003,13(4):245-259.
  • 10Takeshita F, Leifer CA, Gursel I, et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells[J]. J Immunol,2001, 167(7):3555-3558.

二级参考文献11

  • 1Krieg AM. CpG motifs in bacterial DNA and their immune effects[J]. Annu Rev Immunol, 2002, 20: 709-760.
  • 2Rothenfusser S, Hornung V, Towarowski A, et al. Distinct CpG oligonucleotide sequences activate human γδT cells via interferon-α/β[J]. Eur J Immunol, 2001, 31(34): 3525-3534.
  • 3Harandi AM, Eriksson K, Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection[J]. J Virol, 2003, 77(2): 953-962.
  • 4Ashkar AA, Bauer S, Mitchell WJ, et al. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2[J]. J Virol, 2003, 77(16): 8948-8956.
  • 5Gramzinski RA, Doolan DL, Sedegah M. Interleukin-12 and gamma interferon-dependent protection against malaria cinferred by CpG oligodeoxynucleotide in mice[J]. Infect Immun, 2001, 69(3): 1643-1649.
  • 6Walker PS, Scharton KT, Krieg AM, et al. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms[J]. Proc Natl Acad Sci USA, 1999, 96(12): 6970-6975.
  • 7Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides[J]. Nature Immuol, 2004, 4(1): 1-10.
  • 8Krug A, Rothenfusser S, Hornung V, et al. Identification of CpG oligonucleotide dendritic cells[J]. Eur J Immunol, 2001, 31(7): 2154-2163.
  • 9王国兴.Toll样受体及其信号转导[J].细胞与分子免疫学杂志,2002,18(6):666-669. 被引量:9
  • 10罗开忠,杨旭,苏先狮,许允,李良友.时间分辨免疫荧光法检测乙型肝炎病毒标志物[J].中华肝脏病杂志,2003,11(9):569-569. 被引量:61

共引文献4

同被引文献42

  • 1吴翀,丁国富,周红.抗人TLR9抗体对CpG寡核苷酸介导的人外周血单核细胞肿瘤坏死因子-α释放的影响[J].中国临床药理学与治疗学,2006,11(3):324-327. 被引量:3
  • 2蒋为薇,王良喜,丁国富,余双江,周红.CpG-N ODN对CpG-S ODN诱导hPBMC释放TNF-α的抑制作用[J].中国抗生素杂志,2007,32(3):187-190. 被引量:3
  • 3Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 1995,374 : 546-549.
  • 4Krieg AM. Immune effects and mechanisms of action of CpG motifs. Vaccine, 2000,19 :618-622.
  • 5Ahmad-Nejad P, Hacker H, Rutz M, et al. Bacterial CpG-DNA and lipopolysaecharides activate Toll-like receptors at distincct cellular compartments. Eur J immunol,2002,32:1958-1968.
  • 6Takeshita F, Gursel I, Ishii K J, et al. Signal transduetion pathways mediated by the interaction of CpC DNA with Toll-like reeeptor 9. Semin Immunol,2004,16 : 17-22.
  • 7Gursel M,Gursel I,Mostowski HS, et al. CXC116 influences the nature and specificity of CpG-induced immune activation. J Immunol,2006,177 : 1575-1580.
  • 8Kerkmann M, Rothelafusser S, Homung V. et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type Ⅰ IFN synthesis in human plasmacytoid dendritic cells. J Immunol, 2003,170 : 4465-4474.
  • 9Takauji R, Iho S, Takatsuka H, et al. CpG-DNA-indueed IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmaeytoid dendritic cell precursors. J Leukoc Biol, 2002,72 : 1011-1019.
  • 10Underhill DM. Toll-like receptors: networking for success. Eur J Immunol, 2003,33 : 1767-1775.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部